| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Li Wang, Patrick J Hong, Curtis May, Yasir Rehman, Yvgeniy Oparin, Chris J Hong, Brian Y Hong, Mahmood AminiLari, Lucas Gallo, Alka Kaushal, Samantha Craigie, Rachel J Couban, Elena Kum, Harsha Shanthanna, Ira Price, Suneel Upadhye, Mark A Ware, Fiona Campbell, Rachelle Buchbinder, Thomas Agoritsas, Jason W Buss. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ (Clinical research ed.). vol 374. 2021-09-16. PMID:34497047. |
medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. |
2021-09-16 |
2023-08-13 |
Not clear |
| Li Wang, Patrick J Hong, Curtis May, Yasir Rehman, Yvgeniy Oparin, Chris J Hong, Brian Y Hong, Mahmood AminiLari, Lucas Gallo, Alka Kaushal, Samantha Craigie, Rachel J Couban, Elena Kum, Harsha Shanthanna, Ira Price, Suneel Upadhye, Mark A Ware, Fiona Campbell, Rachelle Buchbinder, Thomas Agoritsas, Jason W Buss. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ (Clinical research ed.). vol 374. 2021-09-16. PMID:34497047. |
to determine the benefits and harms of medical cannabis and cannabinoids for chronic pain. |
2021-09-16 |
2023-08-13 |
Not clear |
| Jason W Busse, Patrick Vankrunkelsven, Linan Zeng, Anja Fog Heen, Arnaud Merglen, Fiona Campbell, Lars-Petter Granan, Bert Aertgeerts, Rachelle Buchbinder, Matteo Coen, David Juurlink, Caroline Samer, Reed A C Siemieniuk, Nimisha Kumar, Lynn Cooper, John Brown, Lyubov Lytvyn, Dena Zeraatkar, Li Wang, Gordon H Guyatt, Per O Vandvik, Thomas Agoritsa. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. BMJ (Clinical research ed.). vol 374. 2021-09-16. PMID:34497062. |
medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. |
2021-09-16 |
2023-08-13 |
Not clear |
| Jason W Busse, Patrick Vankrunkelsven, Linan Zeng, Anja Fog Heen, Arnaud Merglen, Fiona Campbell, Lars-Petter Granan, Bert Aertgeerts, Rachelle Buchbinder, Matteo Coen, David Juurlink, Caroline Samer, Reed A C Siemieniuk, Nimisha Kumar, Lynn Cooper, John Brown, Lyubov Lytvyn, Dena Zeraatkar, Li Wang, Gordon H Guyatt, Per O Vandvik, Thomas Agoritsa. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline. BMJ (Clinical research ed.). vol 374. 2021-09-16. PMID:34497062. |
what is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes? |
2021-09-16 |
2023-08-13 |
Not clear |
| Alberto Sainz-Cort, Daniel Jimenez-Garrido, Elena Muñoz-Marron, Raquel Viejo-Sobera, Joost Heeroma, Jose Carlos Bous. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Journal of clinical psychopharmacology. vol 41. issue 5. 2021-09-15. PMID:34412109. |
although δ-9-tetrahydrocannabinol (thc), the main cannabinoid from the cannabis plant, is responsible for the psychotomimetic effects of cannabis, cannabidiol (cbd), the second most abundant cannabinoid in the cannabis plant, does not show any psychotomimetic effect. |
2021-09-15 |
2023-08-13 |
Not clear |
| Annia A Martínez-Peña, Genevieve A Perono, Sarah Alexis Gritis, Reeti Sharma, Shamini Selvakumar, O'Llenecia S Walker, Harmeet Gurm, Alison C Holloway, Sandeep Rah. The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System. International journal of molecular sciences. vol 22. issue 16. 2021-09-15. PMID:34445282. |
the impact of early life exposure to cannabis: the role of the endocannabinoid system. |
2021-09-15 |
2023-08-13 |
Not clear |
| Pasquale Linciano, Fabiana Russo, Cinzia Citti, Francesco Tolomeo, Roberta Paris, Flavia Fulvio, Nicola Pecchioni, Maria Angela Vandelli, Aldo Laganà, Anna Laura Capriotti, Giuseppe Biagini, Luigi Carbone, Giuseppe Gigli, Giuseppe Cannazz. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. Talanta. vol 235. 2021-09-15. PMID:34517579. |
the novel heptyl phorolic acid cannabinoids content in different cannabis sativa l. accessions. |
2021-09-15 |
2023-08-13 |
Not clear |
| Savanah L Saldaña-Shumaker, Alexander J Grenning, Christopher W Cunningha. Modern approaches to the development of synthetic cannabinoid receptor probes. Pharmacology, biochemistry, and behavior. vol 203. 2021-09-14. PMID:33508249. |
whereas the earliest endocannabinoid receptor probes were derivatives of the non-selective phytocannabinoids isolated from cannabis species, modern drug discovery techniques have expanded the definitions of what constitutes a cb1r or cb2r cannabinoid receptor ligand. |
2021-09-14 |
2023-08-13 |
Not clear |
| G Amendola, B Bocca, V Picardo, P Pelosi, B Battistini, F Ruggieri, D Attard Barbini, D De Vita, V N Madia, A Messore, R Di Santo, R Cost. Toxicological aspects of cannabinoid, pesticide and metal levels detected in light Cannabis inflorescences grown in Italy. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. vol 156. 2021-09-14. PMID:34343597. |
toxicological aspects of cannabinoid, pesticide and metal levels detected in light cannabis inflorescences grown in italy. |
2021-09-14 |
2023-08-13 |
human |
| Katrina Weston-Green, Helen Clunas, Carlos Jimenez Naranj. A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis. Frontiers in psychiatry. vol 12. 2021-09-14. PMID:34512404. |
investigations of cannabis compounds in psychiatric and neurological illnesses primarily focus on the major cannabinoids, cannabidiol (cbd) and Δ |
2021-09-14 |
2023-08-13 |
Not clear |
| Kevin F Boehnke, J Ryan Scott, Evangelos Litinas, Suzanne Sisley, David A Williams, Daniel J Clau. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain. The journal of pain. vol 21. issue 5-6. 2021-09-13. PMID:31560957. |
in this cross-sectional survey, we examined whether daily cannabis use frequency was associated with pain severity and interference, quality of life measures relevant to pain (eg, anxiety and depressive symptoms), and cannabis use preferences (administration routes and cannabinoid ratio). |
2021-09-13 |
2023-08-13 |
human |
| Yasaman Razavi, Mina Rashvand, Asrin Sharifi, Amir Haghparast, Fariborz Keyhanfar, Abbas Haghparas. Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain. Neuroscience letters. vol 762. 2021-09-13. PMID:34324957. |
therefore, a non-psychoactive cannabinoid, cannabidiol may be developed as therapeutic agents in conditions, such as persistent inflammatory pain for which primary treatments are insufficient or not possible. |
2021-09-13 |
2023-08-13 |
rat |
| D A Scott, H Dukka, D Saxen. Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction. Journal of dental research. 2021-09-13. PMID:34515556. |
herein, we 1) examine insights obtained from the endocannabinoid system, 2) summarize animal models of exposure to cannabinoid receptor agonists and antagonists, 3) review the evidence suggesting that cannabis and cannabis-derived molecules exert a profound influence on components of the oral microbiome, and 4) assess studies indicating that marijuana and phytocannabinoids compromise the immune response to plaque. |
2021-09-13 |
2023-08-13 |
Not clear |
| D A Scott, H Dukka, D Saxen. Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction. Journal of dental research. 2021-09-13. PMID:34515556. |
furthermore, we address how knowledge of cannabinoid influences in the oral cavity may be exploited to provide potential novel periodontal therapeutics, while recognizing that such medicinal approaches may be most appropriate for nonhabitual marijuana users. |
2021-09-13 |
2023-08-13 |
Not clear |
| Jonathan Vela, Lene Dreyer, Kristian Kjær Petersen, Arendt Nielsen Lars, Kirsten Skjærbæk Duch, Salome Kristense. Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind placebo-controlled trial. Pain. 2021-09-12. PMID:34510141. |
cannabidiol (cbd) is increasingly used as analgesic medication even though the recent international association for the study of pain presidential task force on cannabis and cannabinoid analgesia found a lack of trials examining cbd for pain management. |
2021-09-12 |
2023-08-13 |
Not clear |
| Michael Krämer, Martin Schäper, Kristina Dücker, Alexandra Philipsen, Moritz Losacker, Nadine Dreimüller, Jan Engelmann, Burkhard Madea, Cornelius Hes. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study. Drug testing and analysis. vol 13. issue 9. 2021-09-10. PMID:34114750. |
detectability of cannabinoids in the serum samples of cannabis users: indicators of recent cannabis use? |
2021-09-10 |
2023-08-13 |
Not clear |
| Michael Krämer, Martin Schäper, Kristina Dücker, Alexandra Philipsen, Moritz Losacker, Nadine Dreimüller, Jan Engelmann, Burkhard Madea, Cornelius Hes. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study. Drug testing and analysis. vol 13. issue 9. 2021-09-10. PMID:34114750. |
several studies suggested the utility of minor cannabinoids as indicators of recent cannabis use. |
2021-09-10 |
2023-08-13 |
Not clear |
| Michael Krämer, Martin Schäper, Kristina Dücker, Alexandra Philipsen, Moritz Losacker, Nadine Dreimüller, Jan Engelmann, Burkhard Madea, Cornelius Hes. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study. Drug testing and analysis. vol 13. issue 9. 2021-09-10. PMID:34114750. |
to assess the informative value of serum cannabinoid levels in cannabis users (in total n = 117 patients, including 56 patients who stated an exact time of last cannabis use within 24 h before blood sampling), the detectability of cannabinoids, namely, delta-9-tetrahydrocannabinol (delta-9-thc), 11-hydroxy-delta-9-thc, 11-nor-9-carboxy-delta-9-thc, cannabichromene (cbc), cannabidiol (cbd), cannabinol (cbn), cannabidivarin, tetrahydrocannabivarin, cannabigerol (cbg), cannabicyclol, delta-8-thc, tetrahydrocannabinolic acid a, cannabichromenic acid, cannabidiolic acid (cbda), cannabigerolic acid, cannabicyclolic acid (cbla), 11-nor-9-carboxy-thcv (thcvcooh), and 11-nor-cbn-9-cooh, was investigated. |
2021-09-10 |
2023-08-13 |
Not clear |
| Michael Krämer, Martin Schäper, Kristina Dücker, Alexandra Philipsen, Moritz Losacker, Nadine Dreimüller, Jan Engelmann, Burkhard Madea, Cornelius Hes. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study. Drug testing and analysis. vol 13. issue 9. 2021-09-10. PMID:34114750. |
the interval between cannabis consumption and sample collection (reported by the patients) was not correlated with cannabinoid concentrations. |
2021-09-10 |
2023-08-13 |
Not clear |
| Daniel B Maselli, Michael Camiller. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. vol 19. issue 9. 2021-09-09. PMID:32673642. |
cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently used to relieve gastrointestinal symptoms. |
2021-09-09 |
2023-08-13 |
Not clear |